30 Aug 2011
As global competitive pressure accelerates and regulatory oversight increases, Life Sciences companies today face an unprecedented need to proactively manage research and licensing due diligence, protect business assets and increase revenue. Whether your focus is bio-tech or biopharma, medical devices, life science software or diagnostics, competition is fierce. Life sciences companies are racing to deliver [...]
Read User's Comments(0)






